PP
IRON icon

PDT Partners’s Disc Medicine IRON Stock Holding History

PDT Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,778
Closed -$1.63M – 804
2024
Q4 		$1.63M Buy
+25,778
New +$1.49M 0.14% 248
2024
Q3 		– Sell
-12,103
Closed -$545K – 767
2024
Q2 		$545K Buy
+12,103
New +$411K 0.05% 447

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PDT Partners's IRON Position: Q1 2025 in Review

PDT Partners sold out of Disc Medicine (IRON) in Q1 2025, closing a stake of 25,778 shares — an estimated $1.63M sold.

PDT Partners first reported a position in IRON in Q2 2024 and held it in 2 quarters. The position peaked at $1.63M in Q4 2024. 157 funds tracked by Wall St. Rank hold IRON as of Q1 2025.

  • PDT Partners reported no remaining Disc Medicine position as of Q1 2025 after selling out during the quarter.
  • PDT Partners sold 25,778 Disc Medicine shares in Q1 2025, an estimated $1.63M.
  • PDT Partners first reported a position in Disc Medicine in Q2 2024 and held it in 2 quarters.
  • PDT Partners's Disc Medicine position peaked at $1.63M in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2025.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.